Phase II trial of Modified Vaccinia Ankara (MVA) virus expressing 5T4 and high dose Interleukin-2 (IL-2) in patients with metastatic renal cell carcinoma

Overview of attention for article published in Journal of Translational Medicine, January 2009

Altmetric Badge

Mentioned by

patent: 2 patents

Citations

dimensions_citation: 65 Dimensions

Readers on

mendeley: 49 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

FACTORS

Application WO-2012059750-A2

World Intellectual Property Organisation (WIPO)

RECOMBINANT VIRAL VECTORS AND METHODS FOR INDUCING AN IMMUNE RESPONSE TO YELLOW FEVER…

Application WO-2012040474-A2

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.